Safety Study of Three Formulations of the Dermal Implant ELAPR

This study has been completed.
Information provided by (Responsible Party):
Elastagen Pty Ltd Identifier:
First received: March 22, 2011
Last updated: November 7, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)